REGINA – Patients in Saskatchewan with a rare form of cystic fibrosis will soon have access to a new oral medication.
The province announced Thursday it will provide coverage of Kalydeco starting Sept. 1.
Get weekly health news
Health Minister John Duncan said the “drug can help improve the quality of life and lung function for cystic fibrosis patients.”
The move is being applauded by Cystic Fibrosis Canada, who said it is compassionate action that will benefit the health and well-being of patients.
- Saskatchewan recovery centre, accused of falsifying records, to be investigated by auditor
- ‘Vanderpump Rules’ star Jax Taylor reveals cancer diagnosis, tumour surgery
- Richmond unanimously rejects supervised consumption sites
- A ‘long road’ lies ahead for Regina boy, 4, after alleged medical malpractice
Alberta and Ontario are the only other provinces providing coverage.
Last year, around 130 patients in Saskatchewan were covered for approved cystic fibrosis medication listed by the Saskatchewan drug plan at a cost of roughly $1.75 million.
Comments
Want to discuss? Please read our Commenting Policy first.